$FOR
Forestar Group Inc. Stock $for

$for Overview Financials Valuation SEC Filings Company Website

2022 Q4 Form 10-K Financial Statement

#000140658722000128 Filed on November 17, 2022

Income Statement

Concept	2022 Q4	2022 Q3	2022
Revenue	$216.7M	$381.4M	$1.519B
YoY Change	-46.84%	-8.91%	14.58%
Cost Of Revenue	$169.2M	$292.2M	$1.195B
YoY Change	-49.37%	-14.76%	8.98%
Gross Profit	$47.50M	$89.20M	$324.0M
YoY Change	-35.29%	17.52%	41.36%
Gross Profit Margin	21.92%	23.39%	21.33%
Selling, General & Admin	$22.90M	$23.70M	$93.60M
YoY Change	6.51%	20.3%	36.84%
% of Gross Profit	48.21%	26.57%	28.89%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization	$700.0K	$700.0K	$2.700M
YoY Change	-12.5%	16.67%	0.0%
% of Gross Profit	1.47%	0.78%	0.83%
Operating Expenses	$22.90M	$23.70M	$93.60M
YoY Change	6.51%	20.3%	36.84%
Operating Profit	$24.60M	$65.50M	$230.4M
YoY Change	-52.6%	16.55%	43.28%
Interest Expense	$1.700M	$900.0K	$2.200M
YoY Change	54.55%		57.14%
% of Operating Profit	6.91%	1.37%	0.95%
Other Income/Expense, Net
YoY Change
Pretax Income	$27.90M	$66.40M	$235.8M
YoY Change	-47.85%	12.93%	60.85%
Income Tax	$7.100M	$15.60M	$57.00M
% Of Pretax Income	25.45%	23.49%	24.17%
Net Earnings	$20.80M	$50.80M	$178.8M
YoY Change	-48.64%	15.45%	62.25%
Net Earnings / Revenue	9.6%	13.32%	11.77%
Basic Earnings Per Share	$0.42		$3.59
Diluted Earnings Per Share	$0.42	$1.020M	$3.59
COMMON SHARES
Basic Shares Outstanding	49.77M shares	49.76M shares	49.82M shares
Diluted Shares Outstanding	49.90M shares		49.85M shares

Balance Sheet

Concept	2022 Q4	2022 Q3	2022
SHORT-TERM ASSETS
Cash & Short-Term Investments	$216.4M	$264.8M	$264.8M
YoY Change	33.17%	72.4%	72.4%
Cash & Equivalents	$216.4M	$264.8M	$264.8M
Short-Term Investments
Other Short-Term Assets	$18.10M	$18.90M	$18.90M
YoY Change	44.8%	22.73%	22.73%
Inventory
Prepaid Expenses
Receivables	$13.90M	$11.40M	$11.40M
Other Receivables	$0.00	$0.00	$0.00
Total Short-Term Assets	$248.4M	$295.1M	$295.1M
YoY Change	40.26%	74.2%	74.2%
LONG-TERM ASSETS
Property, Plant & Equipment	$5.600M	$5.700M	$2.036B
YoY Change	33.33%	96.55%	6.3%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments	$500.0K	$500.0K	$500.0K
YoY Change	0.0%	-44.44%	-44.44%
Other Assets
YoY Change
Total Long-Term Assets	$2.093B	$2.048B	$2.048B
YoY Change	5.4%	5.98%	5.98%
TOTAL ASSETS
Total Short-Term Assets	$248.4M	$295.1M	$295.1M
Total Long-Term Assets	$2.093B	$2.048B	$2.048B
Total Assets	$2.341B	$2.343B	$2.343B
YoY Change	8.26%	11.48%	11.48%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$73.00M	$72.20M	$72.20M
YoY Change	36.45%	52.32%	52.32%
Accrued Expenses	$121.9M	$163.0M	$163.0M
YoY Change	-17.64%	16.01%	16.01%
Deferred Revenue	$14.10M	$16.10M
YoY Change	281.08%	177.59%
Short-Term Debt	$0.00	$0.00	$0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities	$359.8M	$379.6M	$379.6M
YoY Change	-0.96%	10.67%	10.67%
LONG-TERM LIABILITIES
Long-Term Debt	$706.4M	$706.0M	$706.0M
YoY Change	0.21%	0.21%	0.21%
Other Long-Term Liabilities	$19.60M	$21.20M	$21.20M
YoY Change	67.52%	52.52%	52.52%
Total Long-Term Liabilities	$726.0M	$727.2M	$727.2M
YoY Change	1.31%	1.22%	1.22%
TOTAL LIABILITIES
Total Short-Term Liabilities	$359.8M	$379.6M	$379.6M
Total Long-Term Liabilities	$726.0M	$727.2M	$727.2M
Total Liabilities	$1.121B	$1.144B	$1.145B
YoY Change	1.49%	5.33%	5.33%
SHAREHOLDERS EQUITY
Retained Earnings	$528.7M	$507.9M
YoY Change	43.05%	54.33%
Common Stock	$690.9M	$690.4M
YoY Change	0.45%	0.67%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$1.220B	$1.198B	$1.198B
YoY Change
Total Liabilities & Shareholders Equity	$2.341B	$2.343B	$2.343B
YoY Change	8.26%	11.48%	11.48%

Cashflow Statement

Concept	2022 Q4	2022 Q3	2022
OPERATING ACTIVITIES
Net Income	$20.80M	$50.80M	$178.8M
YoY Change	-48.64%	15.45%	62.25%
Depreciation, Depletion And Amortization	$700.0K	$700.0K	$2.700M
YoY Change	-12.5%	16.67%	0.0%
Cash From Operating Activities	-$49.80M	$118.9M	$108.7M
YoY Change	-958.62%	217.07%	-135.86%
INVESTING ACTIVITIES
Capital Expenditures	$100.0K	-$300.0K	$3.500M
YoY Change	-93.33%	-72.73%	118.75%
Acquisitions
YoY Change
Other Investing Activities	$1.600M	$0.00	$4.800M
YoY Change	-65.96%	-100.0%	84.62%
Cash From Investing Activities	$1.500M	-$300.0K	$1.300M
YoY Change	-53.13%	-57.14%	30.0%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net			$1.700M
YoY Change			-94.91%
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	-$100.0K	-100.0K	$1.200M
YoY Change	0.0%	-112.5%	-98.05%
NET CHANGE
Cash From Operating Activities	-$49.80M	118.9M	$108.7M
Cash From Investing Activities	$1.500M	-300.0K	$1.300M
Cash From Financing Activities	-$100.0K	-100.0K	$1.200M
Net Change In Cash	-$48.40M	118.5M	$111.2M
YoY Change	-643.82%	215.16%	-146.2%
FREE CASH FLOW
Cash From Operating Activities	-$49.80M	$118.9M	$108.7M
Capital Expenditures	$100.0K	-$300.0K	$3.500M
Free Cash Flow	-$49.90M	$119.2M	$105.2M
YoY Change	-1260.47%	208.81%	-134.53%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2022	dei	Amendment Flag AmendmentFlag	false
CY2022	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2022
CY2022	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	FY
CY2022	dei	Entity Central Index Key EntityCentralIndexKey	0001406587
CY2022Q3	us-gaap	Operating Lease Right Of Use Asset Statement Of Financial Position Extensible List OperatingLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList	http://fasb.org/us-gaap/2022#OtherAssets
CY2021Q3	us-gaap	Operating Lease Right Of Use Asset Statement Of Financial Position Extensible List OperatingLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList	http://fasb.org/us-gaap/2022#OtherAssets
CY2022Q3	us-gaap	Operating Lease Liability Statement Of Financial Position Extensible List OperatingLeaseLiabilityStatementOfFinancialPositionExtensibleList	http://fasb.org/us-gaap/2022#AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent
CY2021Q3	us-gaap	Operating Lease Liability Statement Of Financial Position Extensible List OperatingLeaseLiabilityStatementOfFinancialPositionExtensibleList	http://fasb.org/us-gaap/2022#AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent
CY2022	dei	Document Type DocumentType	10-K
CY2022	dei	Document Annual Report DocumentAnnualReport	true
CY2022	dei	Document Period End Date DocumentPeriodEndDate	2022-09-30
CY2022	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--09-30
CY2022	dei	Document Transition Report DocumentTransitionReport	false
CY2022	dei	Entity File Number EntityFileNumber	001-33662
CY2022	dei	Entity Registrant Name EntityRegistrantName	Forestar Group Inc.
CY2022	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	DE
CY2022	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	26-1336998
CY2022	dei	Entity Address Address Line1 EntityAddressAddressLine1	2221 E. Lamar Blvd.
CY2022	dei	Entity Address Address Line2 EntityAddressAddressLine2	Suite 790
CY2022	dei	Entity Address City Or Town EntityAddressCityOrTown	Arlington
CY2022	dei	Entity Address State Or Province EntityAddressStateOrProvince	TX
CY2022	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	76006
CY2022	dei	City Area Code CityAreaCode	817
CY2022	dei	Local Phone Number LocalPhoneNumber	769-1860
CY2022	dei	Security12b Title Security12bTitle	Common Stock, par value $1.00 per share
CY2022	dei	Trading Symbol TradingSymbol	FOR
CY2022	dei	Security Exchange Name SecurityExchangeName	NYSE
CY2022	dei	Entity Well Known Seasoned Issuer EntityWellKnownSeasonedIssuer	No
CY2022	dei	Entity Voluntary Filers EntityVoluntaryFilers	No
CY2022	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2022	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
CY2022	dei	Entity Filer Category EntityFilerCategory	Accelerated Filer
CY2022	dei	Entity Small Business EntitySmallBusiness	false
CY2022	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
CY2022	dei	Icfr Auditor Attestation Flag IcfrAuditorAttestationFlag	true
CY2022	dei	Entity Shell Company EntityShellCompany	false
CY2022Q1	dei	Entity Public Float EntityPublicFloat	322000000	usd
CY2022Q4	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	49769480	shares
CY2022	dei	Auditor Firm AuditorFirmId	42
CY2022	dei	Auditor Name AuditorName	Ernst & Young LLP
CY2022	dei	Auditor Location AuditorLocation	Fort Worth, Texas
CY2022	dei	Auditor Name AuditorName	Ernst & Young LLP
CY2022	dei	Auditor Location AuditorLocation	Fort Worth, Texas
CY2022Q3	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	264800000	usd
CY2021Q3	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	153600000	usd
CY2022Q3	us-gaap	Inventory Real Estate Land And Land Development Costs InventoryRealEstateLandAndLandDevelopmentCosts	2022400000	usd
CY2021Q3	us-gaap	Inventory Real Estate Land And Land Development Costs InventoryRealEstateLandAndLandDevelopmentCosts	1905200000	usd
CY2022Q3	us-gaap	Equity Method Investments EquityMethodInvestments	500000	usd
CY2021Q3	us-gaap	Equity Method Investments EquityMethodInvestments	900000	usd
CY2022Q3	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	5700000	usd
CY2021Q3	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	2900000	usd
CY2022Q3	us-gaap	Other Assets OtherAssets	49600000	usd
CY2021Q3	us-gaap	Other Assets OtherAssets	39100000	usd
CY2022Q3	us-gaap	Assets Assets	2343000000	usd
CY2021Q3	us-gaap	Assets Assets	2101700000	usd
CY2022Q3	us-gaap	Accounts Payable Current And Noncurrent AccountsPayableCurrentAndNoncurrent	72200000	usd
CY2021Q3	us-gaap	Accounts Payable Current And Noncurrent AccountsPayableCurrentAndNoncurrent	47400000	usd
CY2022Q3	for	Accrued Development Costs AccruedDevelopmentCosts	122300000	usd
CY2021Q3	for	Accrued Development Costs AccruedDevelopmentCosts	104500000	usd
CY2022Q3	us-gaap	Contract With Customer Liability ContractWithCustomerLiability	136200000	usd
CY2021Q3	us-gaap	Contract With Customer Liability ContractWithCustomerLiability	148300000	usd
CY2022Q3	us-gaap	Deferred Income Tax Liabilities Net DeferredIncomeTaxLiabilitiesNet	36900000	usd
CY2021Q3	us-gaap	Deferred Income Tax Liabilities Net DeferredIncomeTaxLiabilitiesNet	24400000	usd
CY2022Q3	us-gaap	Accrued Liabilities Current And Noncurrent AccruedLiabilitiesCurrentAndNoncurrent	70100000	usd
CY2021Q3	us-gaap	Accrued Liabilities Current And Noncurrent AccruedLiabilitiesCurrentAndNoncurrent	56700000	usd
CY2022Q3	us-gaap	Long Term Debt LongTermDebt	706000000.0	usd
CY2021Q3	us-gaap	Long Term Debt LongTermDebt	704500000	usd
CY2022Q3	us-gaap	Liabilities Liabilities	1143700000	usd
CY2021Q3	us-gaap	Liabilities Liabilities	1085800000	usd
CY2022Q3	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2021Q3	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2021Q3	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	1.00
CY2022Q3	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	1.00
CY2021Q3	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	200000000	shares
CY2022Q3	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	200000000	shares
CY2022Q3	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	49761480	shares
CY2021Q3	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	49580389	shares
CY2022Q3	us-gaap	Common Stock Value CommonStockValue	49800000	usd
CY2021Q3	us-gaap	Common Stock Value CommonStockValue	49600000	usd
CY2022Q3	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	640600000	usd
CY2021Q3	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	636200000	usd
CY2022Q3	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	507900000	usd
CY2021Q3	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	329100000	usd
CY2022Q3	us-gaap	Stockholders Equity StockholdersEquity	1198300000	usd
CY2021Q3	us-gaap	Stockholders Equity StockholdersEquity	1014900000	usd
CY2022Q3	us-gaap	Minority Interest MinorityInterest	1000000.0	usd
CY2021Q3	us-gaap	Minority Interest MinorityInterest	1000000.0	usd
CY2022Q3	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	1199300000	usd
CY2021Q3	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	1015900000	usd
CY2022Q3	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	2343000000	usd
CY2021Q3	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	2101700000	usd
CY2022	us-gaap	Revenues Revenues	1519100000	usd
CY2021	us-gaap	Revenues Revenues	1325800000	usd
CY2020	us-gaap	Revenues Revenues	931800000	usd
CY2022	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	1195100000	usd
CY2021	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	1096600000	usd
CY2020	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	813700000	usd
CY2022	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	93600000	usd
CY2021	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	68400000	usd
CY2020	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	45700000	usd
CY2022	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	1200000	usd
CY2021	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	200000	usd
CY2020	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	700000	usd
CY2022	us-gaap	Gain Loss On Disposition Of Assets1 GainLossOnDispositionOfAssets1	3200000	usd
CY2021	us-gaap	Gain Loss On Disposition Of Assets1 GainLossOnDispositionOfAssets1	2500000	usd
CY2020	us-gaap	Gain Loss On Disposition Of Assets1 GainLossOnDispositionOfAssets1	100000	usd
CY2022	us-gaap	Interest And Other Income InterestAndOtherIncome	1000000.0	usd
CY2021	us-gaap	Interest And Other Income InterestAndOtherIncome	1200000	usd
CY2020	us-gaap	Interest And Other Income InterestAndOtherIncome	4900000	usd
CY2022	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	0	usd
CY2021	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	-18100000	usd
CY2020	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	0	usd
CY2022	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	235800000	usd
CY2021	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	146600000	usd
CY2020	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	78100000	usd
CY2022	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	57000000.0	usd
CY2021	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	36100000	usd
CY2020	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	16400000	usd
CY2022	us-gaap	Profit Loss ProfitLoss	178800000	usd
CY2021	us-gaap	Profit Loss ProfitLoss	110500000	usd
CY2020	us-gaap	Profit Loss ProfitLoss	61700000	usd
CY2022	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	0	usd
CY2021	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	300000	usd
CY2020	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	900000	usd
CY2022	us-gaap	Net Income Loss NetIncomeLoss	178800000	usd
CY2021	us-gaap	Net Income Loss NetIncomeLoss	110200000	usd
CY2020	us-gaap	Net Income Loss NetIncomeLoss	60800000	usd
CY2022	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	3.59
CY2021	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	2.25
CY2020	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	1.26
CY2022	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	49800000	shares
CY2021	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	48900000	shares
CY2020	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	48000000.0	shares
CY2022	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	3.59
CY2021	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	2.25
CY2020	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	1.26
CY2022	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	49800000	shares
CY2021	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	49000000.0	shares
CY2020	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	48100000	shares
CY2019Q3	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	808900000	usd
CY2020	us-gaap	Profit Loss ProfitLoss	61700000	usd
CY2020	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	100000	usd
CY2020	us-gaap	Adjustments Related To Tax Withholding For Share Based Compensation AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation	300000	usd
CY2020	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	2000000.0	usd
CY2020	us-gaap	Minority Interest Decrease From Distributions To Noncontrolling Interest Holders MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders	600000	usd
CY2020Q3	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	871800000	usd
CY2021	us-gaap	Profit Loss ProfitLoss	110500000	usd
CY2021	us-gaap	Stock Issued During Period Shares New Issues StockIssuedDuringPeriodSharesNewIssues	1448520	shares
CY2021	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	33400000	usd
CY2021	us-gaap	Minority Interest Decrease From Redemptions MinorityInterestDecreaseFromRedemptions	-1800000	usd
CY2021	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	100000	usd
CY2021	us-gaap	Adjustments Related To Tax Withholding For Share Based Compensation AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation	600000	usd
CY2021	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	2600000	usd
CY2021	us-gaap	Minority Interest Decrease From Distributions To Noncontrolling Interest Holders MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders	100000	usd
CY2021Q3	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	1015900000	usd
CY2022	us-gaap	Profit Loss ProfitLoss	178800000	usd
CY2022	us-gaap	Stock Issued During Period Shares New Issues StockIssuedDuringPeriodSharesNewIssues	84547	shares
CY2022	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	1700000	usd
CY2022	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	100000	usd
CY2022	us-gaap	Adjustments Related To Tax Withholding For Share Based Compensation AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation	500000	usd
CY2022	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	3300000	usd
CY2022Q3	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	1199300000	usd
CY2022	us-gaap	Profit Loss ProfitLoss	178800000	usd
CY2021	us-gaap	Profit Loss ProfitLoss	110500000	usd
CY2020	us-gaap	Profit Loss ProfitLoss	61700000	usd
CY2022	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	2700000	usd
CY2021	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	2700000	usd
CY2020	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	4900000	usd
CY2022	us-gaap	Increase Decrease In Deferred Income Taxes IncreaseDecreaseInDeferredIncomeTaxes	-12500000	usd
CY2021	us-gaap	Increase Decrease In Deferred Income Taxes IncreaseDecreaseInDeferredIncomeTaxes	-19200000	usd
CY2020	us-gaap	Increase Decrease In Deferred Income Taxes IncreaseDecreaseInDeferredIncomeTaxes	-23100000	usd
CY2022	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	1200000	usd
CY2021	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	200000	usd
CY2020	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	700000	usd
CY2022	us-gaap	Share Based Compensation ShareBasedCompensation	3300000	usd
CY2021	us-gaap	Share Based Compensation ShareBasedCompensation	2600000	usd
CY2020	us-gaap	Share Based Compensation ShareBasedCompensation	2000000.0	usd
CY2022	us-gaap	Production Related Impairments Or Charges ProductionRelatedImpairmentsOrCharges	12500000	usd
CY2021	us-gaap	Production Related Impairments Or Charges ProductionRelatedImpairmentsOrCharges	3000000.0	usd
CY2020	us-gaap	Production Related Impairments Or Charges ProductionRelatedImpairmentsOrCharges	900000	usd
CY2022	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	0	usd
CY2021	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	-18100000	usd
CY2020	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	0	usd
CY2022	us-gaap	Gain Loss On Disposition Of Assets1 GainLossOnDispositionOfAssets1	3200000	usd
CY2021	us-gaap	Gain Loss On Disposition Of Assets1 GainLossOnDispositionOfAssets1	2500000	usd
CY2020	us-gaap	Gain Loss On Disposition Of Assets1 GainLossOnDispositionOfAssets1	100000	usd
CY2022	us-gaap	Other Noncash Income Expense OtherNoncashIncomeExpense	0	usd
CY2021	us-gaap	Other Noncash Income Expense OtherNoncashIncomeExpense	-100000	usd
CY2020	us-gaap	Other Noncash Income Expense OtherNoncashIncomeExpense	-100000	usd
CY2022	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	142300000	usd
CY2021	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	585900000	usd
CY2020	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	281700000	usd
CY2022	us-gaap	Increase Decrease In Other Operating Assets IncreaseDecreaseInOtherOperatingAssets	1600000	usd
CY2021	us-gaap	Increase Decrease In Other Operating Assets IncreaseDecreaseInOtherOperatingAssets	14800000	usd
CY2020	us-gaap	Increase Decrease In Other Operating Assets IncreaseDecreaseInOtherOperatingAssets	3400000	usd
CY2022	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	40900000	usd
CY2021	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	28000000.0	usd
CY2020	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	15000000.0	usd
CY2022	us-gaap	Increase Decrease In Accrued Liabilities And Other Operating Liabilities IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities	17800000	usd
CY2021	us-gaap	Increase Decrease In Accrued Liabilities And Other Operating Liabilities IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities	60100000	usd
CY2020	us-gaap	Increase Decrease In Accrued Liabilities And Other Operating Liabilities IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities	9000000.0	usd
CY2022	us-gaap	Increase Decrease In Contract With Customer Liability IncreaseDecreaseInContractWithCustomerLiability	-11500000	usd
CY2021	us-gaap	Increase Decrease In Contract With Customer Liability IncreaseDecreaseInContractWithCustomerLiability	49700000	usd
CY2020	us-gaap	Increase Decrease In Contract With Customer Liability IncreaseDecreaseInContractWithCustomerLiability	3900000	usd
CY2022	us-gaap	Increase Decrease In Income Taxes Receivable IncreaseDecreaseInIncomeTaxesReceivable	0	usd
CY2021	us-gaap	Increase Decrease In Income Taxes Receivable IncreaseDecreaseInIncomeTaxesReceivable	-6300000	usd
CY2020	us-gaap	Increase Decrease In Income Taxes Receivable IncreaseDecreaseInIncomeTaxesReceivable	3100000	usd
CY2022	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	108700000	usd
CY2021	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-303100000	usd
CY2020	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-168400000	usd
CY2022	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	3500000	usd
CY2021	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	1600000	usd
CY2020	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	600000	usd
CY2022	us-gaap	Proceeds From Equity Method Investment Dividends Or Distributions Return Of Capital ProceedsFromEquityMethodInvestmentDividendsOrDistributionsReturnOfCapital	1600000	usd
CY2021	us-gaap	Proceeds From Equity Method Investment Dividends Or Distributions Return Of Capital ProceedsFromEquityMethodInvestmentDividendsOrDistributionsReturnOfCapital	2600000	usd
CY2020	us-gaap	Proceeds From Equity Method Investment Dividends Or Distributions Return Of Capital ProceedsFromEquityMethodInvestmentDividendsOrDistributionsReturnOfCapital	4300000	usd
CY2022	us-gaap	Proceeds From Sales Of Assets Investing Activities ProceedsFromSalesOfAssetsInvestingActivities	3200000	usd
CY2021	us-gaap	Proceeds From Sales Of Assets Investing Activities ProceedsFromSalesOfAssetsInvestingActivities	0	usd
CY2020	us-gaap	Proceeds From Sales Of Assets Investing Activities ProceedsFromSalesOfAssetsInvestingActivities	1300000	usd
CY2022	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	1300000	usd
CY2021	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	1000000.0	usd
CY2020	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	5000000.0	usd
CY2022	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	1700000	usd
CY2021	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	33400000	usd
CY2020	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	0	usd
CY2022	us-gaap	Proceeds From Notes Payable ProceedsFromNotesPayable	0	usd
CY2021	us-gaap	Proceeds From Notes Payable ProceedsFromNotesPayable	458000000.0	usd
CY2020	us-gaap	Proceeds From Notes Payable ProceedsFromNotesPayable	300000000.0	usd
CY2022	us-gaap	Repayments Of Notes Payable RepaymentsOfNotesPayable	0	usd
CY2021	us-gaap	Repayments Of Notes Payable RepaymentsOfNotesPayable	422000000.0	usd
CY2020	us-gaap	Repayments Of Notes Payable RepaymentsOfNotesPayable	118900000	usd
CY2022	us-gaap	Payments Of Financing Costs PaymentsOfFinancingCosts	0	usd
CY2021	us-gaap	Payments Of Financing Costs PaymentsOfFinancingCosts	4900000	usd
CY2020	us-gaap	Payments Of Financing Costs PaymentsOfFinancingCosts	5300000	usd
CY2022	us-gaap	Proceeds From Payments To Minority Shareholders ProceedsFromPaymentsToMinorityShareholders	0	usd
CY2021	us-gaap	Proceeds From Payments To Minority Shareholders ProceedsFromPaymentsToMinorityShareholders	-2400000	usd
CY2020	us-gaap	Proceeds From Payments To Minority Shareholders ProceedsFromPaymentsToMinorityShareholders	0	usd
CY2022	us-gaap	Payments To Minority Shareholders PaymentsToMinorityShareholders	0	usd
CY2021	us-gaap	Payments To Minority Shareholders PaymentsToMinorityShareholders	100000	usd
CY2020	us-gaap	Payments To Minority Shareholders PaymentsToMinorityShareholders	600000	usd
CY2022	us-gaap	Payments Related To Tax Withholding For Share Based Compensation PaymentsRelatedToTaxWithholdingForShareBasedCompensation	500000	usd
CY2021	us-gaap	Payments Related To Tax Withholding For Share Based Compensation PaymentsRelatedToTaxWithholdingForShareBasedCompensation	600000	usd
CY2020	us-gaap	Payments Related To Tax Withholding For Share Based Compensation PaymentsRelatedToTaxWithholdingForShareBasedCompensation	300000	usd
CY2022	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	1200000	usd
CY2021	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	61400000	usd
CY2020	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	174900000	usd
CY2022	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	111200000	usd
CY2021	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-240700000	usd
CY2020	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	11500000	usd
CY2021Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	153600000	usd
CY2020Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	394300000	usd
CY2019Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	382800000	usd
CY2022Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	264800000	usd
CY2021Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	153600000	usd
CY2020Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	394300000	usd
CY2022	us-gaap	Notes Issued1 NotesIssued1	0	usd
CY2021	us-gaap	Notes Issued1 NotesIssued1	12500000	usd
CY2020	us-gaap	Notes Issued1 NotesIssued1	0	usd
CY2022	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	42400000	usd
CY2021	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	4300000	usd
CY2020	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	-3100000	usd
CY2022	us-gaap	Use Of Estimates UseOfEstimates	<div style="text-indent:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Use of Estimates</span></div><div style="text-indent:22.5pt"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions. These estimates and assumptions affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ materially from those estimates.</span></div>
CY2022Q3	us-gaap	Deposits Assets DepositsAssets	10000000	usd
CY2021Q3	us-gaap	Deposits Assets DepositsAssets	10400000	usd
CY2022	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Expiration Period SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod	P4Y6M
CY2022Q3	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	7300000	usd
CY2021Q3	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	3800000	usd
CY2022Q3	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	1600000	usd
CY2021Q3	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	900000	usd
CY2022Q3	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	5700000	usd
CY2021Q3	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	2900000	usd
CY2022	us-gaap	Depreciation Depreciation	700000	usd
CY2021	us-gaap	Depreciation Depreciation	400000	usd
CY2020	us-gaap	Depreciation Depreciation	300000	usd
CY2021	us-gaap	Inventory Write Down InventoryWriteDown	3800000	usd
CY2022Q3	us-gaap	Inventory Real Estate Land And Land Development Costs InventoryRealEstateLandAndLandDevelopmentCosts	2022400000	usd
CY2021Q3	us-gaap	Inventory Real Estate Land And Land Development Costs InventoryRealEstateLandAndLandDevelopmentCosts	1905200000	usd
CY2022	us-gaap	Payments To Acquire Residential Real Estate PaymentsToAcquireResidentialRealEstate	320700000	usd
CY2022	us-gaap	Payments To Develop Real Estate Assets PaymentsToDevelopRealEstateAssets	1100000000	usd
CY2022	us-gaap	Inventory Write Down InventoryWriteDown	3800000	usd
CY2020	us-gaap	Inventory Write Down InventoryWriteDown	0	usd
CY2022	for	Due Diligence Write Offs DueDiligenceWriteOffs	8700000	usd
CY2021	for	Due Diligence Write Offs DueDiligenceWriteOffs	3000000	usd
CY2020	for	Due Diligence Write Offs DueDiligenceWriteOffs	900000	usd
CY2022	us-gaap	Contract With Customer Liability Revenue Recognized ContractWithCustomerLiabilityRevenueRecognized	26800000	usd
CY2021	us-gaap	Contract With Customer Liability Revenue Recognized ContractWithCustomerLiabilityRevenueRecognized	0	usd
CY2020	us-gaap	Contract With Customer Liability Revenue Recognized ContractWithCustomerLiabilityRevenueRecognized	0	usd
CY2022	us-gaap	Other Revenue Expense From Real Estate Operations OtherRevenueExpenseFromRealEstateOperations	36800000	usd
CY2021	us-gaap	Other Revenue Expense From Real Estate Operations OtherRevenueExpenseFromRealEstateOperations	32700000	usd
CY2020	us-gaap	Other Revenue Expense From Real Estate Operations OtherRevenueExpenseFromRealEstateOperations	51500000	usd
CY2022	us-gaap	Revenues Revenues	1519100000	usd
CY2021	us-gaap	Revenues Revenues	1325800000	usd
CY2020	us-gaap	Revenues Revenues	931800000	usd
CY2022	us-gaap	Contract With Customer Liability Revenue Recognized ContractWithCustomerLiabilityRevenueRecognized	26800000	usd
CY2021Q3	us-gaap	Real Estate Inventory Capitalized Interest Costs RealEstateInventoryCapitalizedInterestCosts	53700000	usd
CY2020Q3	us-gaap	Real Estate Inventory Capitalized Interest Costs RealEstateInventoryCapitalizedInterestCosts	48700000	usd
CY2019Q3	us-gaap	Real Estate Inventory Capitalized Interest Costs RealEstateInventoryCapitalizedInterestCosts	23700000	usd
CY2022	us-gaap	Interest Costs Incurred InterestCostsIncurred	32900000	usd
CY2021	us-gaap	Interest Costs Incurred InterestCostsIncurred	41500000	usd
CY2020	us-gaap	Interest Costs Incurred InterestCostsIncurred	43300000	usd
CY2022	us-gaap	Real Estate Inventory Capitalized Interest Costs Cost Of Sales1 RealEstateInventoryCapitalizedInterestCostsCostOfSales1	34100000	usd
CY2021	us-gaap	Real Estate Inventory Capitalized Interest Costs Cost Of Sales1 RealEstateInventoryCapitalizedInterestCostsCostOfSales1	36500000	usd
CY2020	us-gaap	Real Estate Inventory Capitalized Interest Costs Cost Of Sales1 RealEstateInventoryCapitalizedInterestCostsCostOfSales1	18300000	usd
CY2022Q3	us-gaap	Real Estate Inventory Capitalized Interest Costs RealEstateInventoryCapitalizedInterestCosts	52500000	usd
CY2021Q3	us-gaap	Real Estate Inventory Capitalized Interest Costs RealEstateInventoryCapitalizedInterestCosts	53700000	usd
CY2020Q3	us-gaap	Real Estate Inventory Capitalized Interest Costs RealEstateInventoryCapitalizedInterestCosts	48700000	usd
CY2022Q3	us-gaap	Accounts And Notes Receivable Net AccountsAndNotesReceivableNet	0	usd
CY2021Q3	us-gaap	Accounts And Notes Receivable Net AccountsAndNotesReceivableNet	700000	usd
CY2022Q3	us-gaap	Notes Receivable Related Parties NotesReceivableRelatedParties	11400000	usd
CY2021Q3	us-gaap	Notes Receivable Related Parties NotesReceivableRelatedParties	400000	usd
CY2022Q3	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	7500000	usd
CY2021Q3	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	6900000	usd
CY2022Q3	us-gaap	Prepaid Expense Current And Noncurrent PrepaidExpenseCurrentAndNoncurrent	18900000	usd
CY2021Q3	us-gaap	Prepaid Expense Current And Noncurrent PrepaidExpenseCurrentAndNoncurrent	15400000	usd
CY2022Q3	us-gaap	Deposits Assets DepositsAssets	10000000.0	usd
CY2021Q3	us-gaap	Deposits Assets DepositsAssets	10400000	usd
CY2022Q3	us-gaap	Other Assets Miscellaneous OtherAssetsMiscellaneous	1800000	usd
CY2021Q3	us-gaap	Other Assets Miscellaneous OtherAssetsMiscellaneous	5300000	usd
CY2022Q3	us-gaap	Other Assets OtherAssets	49600000	usd
CY2021Q3	us-gaap	Other Assets OtherAssets	39100000	usd
CY2022Q3	us-gaap	Employee Related Liabilities Current And Noncurrent EmployeeRelatedLiabilitiesCurrentAndNoncurrent	11600000	usd
CY2021Q3	us-gaap	Employee Related Liabilities Current And Noncurrent EmployeeRelatedLiabilitiesCurrentAndNoncurrent	7900000	usd
CY2022Q3	us-gaap	Accrual For Taxes Other Than Income Taxes Current And Noncurrent AccrualForTaxesOtherThanIncomeTaxesCurrentAndNoncurrent	6200000	usd
CY2021Q3	us-gaap	Accrual For Taxes Other Than Income Taxes Current And Noncurrent AccrualForTaxesOtherThanIncomeTaxesCurrentAndNoncurrent	3400000	usd
CY2022Q3	us-gaap	Operating Lease Liability OperatingLeaseLiability	8100000	usd
CY2021Q3	us-gaap	Operating Lease Liability OperatingLeaseLiability	7300000	usd
CY2022Q3	us-gaap	Interest Payable Current And Noncurrent InterestPayableCurrentAndNoncurrent	8000000.0	usd
CY2021Q3	us-gaap	Interest Payable Current And Noncurrent InterestPayableCurrentAndNoncurrent	8500000	usd
CY2022Q3	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	16100000	usd
CY2021Q3	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	5800000	usd
CY2022Q3	us-gaap	Deferred Revenue DeferredRevenue	4100000	usd
CY2021Q3	us-gaap	Deferred Revenue DeferredRevenue	6800000	usd
CY2022Q3	us-gaap	Taxes Payable Current And Noncurrent TaxesPayableCurrentAndNoncurrent	8200000	usd
CY2021Q3	us-gaap	Taxes Payable Current And Noncurrent TaxesPayableCurrentAndNoncurrent	6800000	usd
CY2022Q3	us-gaap	Other Accrued Liabilities Current And Noncurrent OtherAccruedLiabilitiesCurrentAndNoncurrent	6800000	usd
CY2021Q3	us-gaap	Other Accrued Liabilities Current And Noncurrent OtherAccruedLiabilitiesCurrentAndNoncurrent	8900000	usd
CY2022Q3	us-gaap	Other Liabilities OtherLiabilities	1000000.0	usd
CY2021Q3	us-gaap	Other Liabilities OtherLiabilities	1300000	usd
CY2022Q3	us-gaap	Accrued Liabilities Current And Noncurrent AccruedLiabilitiesCurrentAndNoncurrent	70100000	usd
CY2021Q3	us-gaap	Accrued Liabilities Current And Noncurrent AccruedLiabilitiesCurrentAndNoncurrent	56700000	usd
CY2022Q3	us-gaap	Line Of Credit LineOfCredit	0	usd
CY2021Q3	us-gaap	Line Of Credit LineOfCredit	0	usd
CY2022Q3	us-gaap	Long Term Debt LongTermDebt	706000000.0	usd
CY2021Q3	us-gaap	Long Term Debt LongTermDebt	704500000	usd
CY2022Q3	us-gaap	Line Of Credit Facility Current Borrowing Capacity LineOfCreditFacilityCurrentBorrowingCapacity	410000000	usd
CY2022Q3	us-gaap	Line Of Credit Facility Maximum Borrowing Capacity LineOfCreditFacilityMaximumBorrowingCapacity	600000000	usd
CY2022Q3	for	Letterof Credit Maximum Borrowing Capacity LetterofCreditMaximumBorrowingCapacity	100000000	usd
CY2022Q3	for	Letterof Credit Maximum Borrowing Capacity Percentageof Revolving Credit Commitment LetterofCreditMaximumBorrowingCapacityPercentageofRevolvingCreditCommitment	0.50
CY2022	us-gaap	Proceeds From Long Term Lines Of Credit ProceedsFromLongTermLinesOfCredit	0	usd
CY2022	us-gaap	Repayments Of Long Term Lines Of Credit RepaymentsOfLongTermLinesOfCredit	0	usd
CY2022Q3	us-gaap	Line Of Credit LineOfCredit	0	usd
CY2022Q3	us-gaap	Letters Of Credit Outstanding Amount LettersOfCreditOutstandingAmount	53300000	usd
CY2022Q3	us-gaap	Line Of Credit Facility Remaining Borrowing Capacity LineOfCreditFacilityRemainingBorrowingCapacity	356700000	usd
CY2020Q2	for	Debt Repurchase Program Authorized Amount DebtRepurchaseProgramAuthorizedAmount	30000000	usd
CY2022Q3	for	Debt Repurchase Program Authorized Amount DebtRepurchaseProgramAuthorizedAmount	30000000	usd
CY2022	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	3.59
CY2022	us-gaap	Net Income Loss NetIncomeLoss	178800000	usd
CY2021	us-gaap	Net Income Loss NetIncomeLoss	110200000	usd
CY2020	us-gaap	Net Income Loss NetIncomeLoss	60800000	usd
CY2022	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	49818132	shares
CY2021	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	48901987	shares
CY2020	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	48037018	shares
CY2022	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	31762	shares
CY2021	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	73674	shares
CY2020	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	57093	shares
CY2022	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	49849894	shares
CY2021	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	48975661	shares
CY2020	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	48094111	shares
CY2020	us-gaap	Defined Contribution Plan Cost Recognized DefinedContributionPlanCostRecognized	400000	usd
CY2021	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	2.25
CY2020	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	1.26
CY2022	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	3.59
CY2021	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	2.25
CY2020	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	1.26
CY2022	us-gaap	Current Federal Tax Expense Benefit CurrentFederalTaxExpenseBenefit	38300000	usd
CY2021	us-gaap	Current Federal Tax Expense Benefit CurrentFederalTaxExpenseBenefit	14300000	usd
CY2020	us-gaap	Current Federal Tax Expense Benefit CurrentFederalTaxExpenseBenefit	-7600000	usd
CY2022	us-gaap	Current State And Local Tax Expense Benefit CurrentStateAndLocalTaxExpenseBenefit	6200000	usd
CY2021	us-gaap	Current State And Local Tax Expense Benefit CurrentStateAndLocalTaxExpenseBenefit	2600000	usd
CY2020	us-gaap	Current State And Local Tax Expense Benefit CurrentStateAndLocalTaxExpenseBenefit	900000	usd
CY2022	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	44500000	usd
CY2021	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	16900000	usd
CY2020	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	-6700000	usd
CY2022	us-gaap	Deferred Federal Income Tax Expense Benefit DeferredFederalIncomeTaxExpenseBenefit	10200000	usd
CY2021	us-gaap	Deferred Federal Income Tax Expense Benefit DeferredFederalIncomeTaxExpenseBenefit	15800000	usd
CY2020	us-gaap	Deferred Federal Income Tax Expense Benefit DeferredFederalIncomeTaxExpenseBenefit	21200000	usd
CY2022	us-gaap	Deferred State And Local Income Tax Expense Benefit DeferredStateAndLocalIncomeTaxExpenseBenefit	2300000	usd
CY2021	us-gaap	Deferred State And Local Income Tax Expense Benefit DeferredStateAndLocalIncomeTaxExpenseBenefit	3400000	usd
CY2020	us-gaap	Deferred State And Local Income Tax Expense Benefit DeferredStateAndLocalIncomeTaxExpenseBenefit	1900000	usd
CY2022	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	12500000	usd
CY2021	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	19200000	usd
CY2020	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	23100000	usd
CY2022	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	57000000.0	usd
CY2021	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	36100000	usd
CY2020	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	16400000	usd
CY2021	us-gaap	Effective Income Tax Rate Reconciliation Minority Interest Income Expense EffectiveIncomeTaxRateReconciliationMinorityInterestIncomeExpense	0
CY2020	us-gaap	Effective Income Tax Rate Reconciliation Minority Interest Income Expense EffectiveIncomeTaxRateReconciliationMinorityInterestIncomeExpense	-0.003
CY2022	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.210
CY2021	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.210
CY2020	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.210
CY2022	us-gaap	Effective Income Tax Rate Reconciliation State And Local Income Taxes EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes	0.030
CY2021	us-gaap	Effective Income Tax Rate Reconciliation State And Local Income Taxes EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes	0.033
CY2020	us-gaap	Effective Income Tax Rate Reconciliation State And Local Income Taxes EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes	0.029
CY2022	us-gaap	Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance	-0.001
CY2021	us-gaap	Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance	0
CY2020	us-gaap	Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance	-0.001
CY2022	us-gaap	Effective Income Tax Rate Reconciliation Prior Year Income Taxes EffectiveIncomeTaxRateReconciliationPriorYearIncomeTaxes	0
CY2021	us-gaap	Effective Income Tax Rate Reconciliation Prior Year Income Taxes EffectiveIncomeTaxRateReconciliationPriorYearIncomeTaxes	0
CY2020	us-gaap	Effective Income Tax Rate Reconciliation Prior Year Income Taxes EffectiveIncomeTaxRateReconciliationPriorYearIncomeTaxes	-0.020
CY2022	us-gaap	Effective Income Tax Rate Reconciliation Minority Interest Income Expense EffectiveIncomeTaxRateReconciliationMinorityInterestIncomeExpense	0
CY2022	us-gaap	Effective Income Tax Rate Reconciliation Change In Enacted Tax Rate EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate	0
CY2021	us-gaap	Effective Income Tax Rate Reconciliation Change In Enacted Tax Rate EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate	0
CY2020	us-gaap	Effective Income Tax Rate Reconciliation Change In Enacted Tax Rate EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate	-0.010
CY2022	us-gaap	Effective Income Tax Rate Reconciliation Other Adjustments EffectiveIncomeTaxRateReconciliationOtherAdjustments	0.003
CY2021	us-gaap	Effective Income Tax Rate Reconciliation Other Adjustments EffectiveIncomeTaxRateReconciliationOtherAdjustments	0.003
CY2020	us-gaap	Effective Income Tax Rate Reconciliation Other Adjustments EffectiveIncomeTaxRateReconciliationOtherAdjustments	0.005
CY2022	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.242
CY2021	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.246
CY2020	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.210
CY2021	us-gaap	Income Tax Reconciliation Other Adjustments IncomeTaxReconciliationOtherAdjustments	2300000	usd
CY2022Q3	us-gaap	Deferred Tax Assets Inventory DeferredTaxAssetsInventory	11500000	usd
CY2021Q3	us-gaap	Deferred Tax Assets Inventory DeferredTaxAssetsInventory	14200000	usd
CY2022Q3	us-gaap	Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Employee Benefits DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsEmployeeBenefits	2800000	usd
CY2021Q3	us-gaap	Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Employee Benefits DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsEmployeeBenefits	1900000	usd
CY2022Q3	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	1200000	usd
CY2021Q3	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	1400000	usd
CY2022Q3	us-gaap	Deferred Tax Assets Other DeferredTaxAssetsOther	200000	usd
CY2021Q3	us-gaap	Deferred Tax Assets Other DeferredTaxAssetsOther	200000	usd
CY2022Q3	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	15700000	usd
CY2021Q3	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	17700000	usd
CY2022Q3	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	1000000.0	usd
CY2021Q3	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	1200000	usd
CY2022Q3	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet	14700000	usd
CY2021Q3	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet	16500000	usd
CY2022Q3	us-gaap	Deferred Tax Liabilities Tax Deferred Income DeferredTaxLiabilitiesTaxDeferredIncome	51600000	usd
CY2021Q3	us-gaap	Deferred Tax Liabilities Tax Deferred Income DeferredTaxLiabilitiesTaxDeferredIncome	40900000	usd
CY2022Q3	us-gaap	Deferred Income Tax Liabilities DeferredIncomeTaxLiabilities	51600000	usd
CY2021Q3	us-gaap	Deferred Income Tax Liabilities DeferredIncomeTaxLiabilities	40900000	usd
CY2022Q3	us-gaap	Deferred Tax Liabilities DeferredTaxLiabilities	36900000	usd
CY2021Q3	us-gaap	Deferred Tax Liabilities DeferredTaxLiabilities	24400000	usd
CY2022Q3	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	1000000	usd
CY2021Q3	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	1200000	usd
CY2021Q3	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	0	usd
CY2020Q3	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	0	usd
CY2019Q3	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	1600000	usd
CY2022	us-gaap	Unrecognized Tax Benefits Period Increase Decrease UnrecognizedTaxBenefitsPeriodIncreaseDecrease	0	usd
CY2021	us-gaap	Unrecognized Tax Benefits Period Increase Decrease UnrecognizedTaxBenefitsPeriodIncreaseDecrease	0	usd
CY2020	us-gaap	Unrecognized Tax Benefits Period Increase Decrease UnrecognizedTaxBenefitsPeriodIncreaseDecrease	-1600000	usd
CY2022Q3	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	0	usd
CY2021Q3	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	0	usd
CY2020Q3	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	0	usd
CY2022Q3	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	0	usd
CY2021Q3	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	0	usd
CY2020	us-gaap	Unrecognized Tax Benefits Period Increase Decrease UnrecognizedTaxBenefitsPeriodIncreaseDecrease	-1600000	usd
CY2020	us-gaap	Unrecognized Tax Benefits Period Increase Decrease UnrecognizedTaxBenefitsPeriodIncreaseDecrease	-1600000	usd
CY2022	us-gaap	Unrecognized Tax Benefits Interest On Income Taxes Expense UnrecognizedTaxBenefitsInterestOnIncomeTaxesExpense	0	usd
CY2021	us-gaap	Unrecognized Tax Benefits Interest On Income Taxes Expense UnrecognizedTaxBenefitsInterestOnIncomeTaxesExpense	0	usd
CY2020	us-gaap	Unrecognized Tax Benefits Interest On Income Taxes Expense UnrecognizedTaxBenefitsInterestOnIncomeTaxesExpense	0	usd
CY2022Q3	us-gaap	Unrecognized Tax Benefits Interest On Income Taxes Accrued UnrecognizedTaxBenefitsInterestOnIncomeTaxesAccrued	0	usd
CY2019Q3	for	Equity Securities Registered Value EquitySecuritiesRegisteredValue	750000000	usd
CY2019Q3	for	At The Market Equity Offering Program Common Stock Available For Issuance AtTheMarketEquityOfferingProgramCommonStockAvailableForIssuance	300000000	usd
CY2022Q3	for	At The Market Equity Offering Program Common Stock Issued AtTheMarketEquityOfferingProgramCommonStockIssued	84547	shares
CY2022	for	At The Market Equity Offering Program Net Proceeds AtTheMarketEquityOfferingProgramNetProceeds	1700000	usd
CY2022	us-gaap	Adjustments To Additional Paid In Capital Stock Issued Issuance Costs AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts	100000	usd
CY2022Q3	for	Common Stock Availablefor Issuance Value Remaining CommonStockAvailableforIssuanceValueRemaining	748200000	usd
CY2022Q3	for	At The Market Equity Offering Program Common Stock Available For Issuance AtTheMarketEquityOfferingProgramCommonStockAvailableForIssuance	298200000	usd
CY2022	us-gaap	Defined Contribution Plan Cost Recognized DefinedContributionPlanCostRecognized	800000	usd
CY2021	us-gaap	Defined Contribution Plan Cost Recognized DefinedContributionPlanCostRecognized	600000	usd
CY2021Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber	387154	shares
CY2021Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue	20.70
CY2020Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber	285863	shares
CY2020Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue	17.47
CY2019Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber	200960	shares
CY2019Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue	19.68
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod	394786	shares
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue	17.76
CY2021	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod	234000	shares
CY2021	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue	23.13
CY2020	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod	181325	shares
CY2020	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue	16.11
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod	123389	shares
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue	19.98
CY2021	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod	92159	shares
CY2021	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue	19.08
CY2020	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod	79432	shares
CY2020	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue	19.58
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeited In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod	36600	shares
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeitures Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue	19.98
CY2021	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeited In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod	40550	shares
CY2021	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeitures Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue	19.66
CY2020	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeited In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod	16990	shares
CY2020	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeitures Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue	19.10
CY2022Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber	621951	shares
CY2022Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue	18.94
CY2021Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber	387154	shares
CY2021Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue	20.70
CY2020Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber	285863	shares
CY2020Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue	17.47
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period Total Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue	2500000	usd
CY2020	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period Total Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue	1600000	usd
CY2021	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period Total Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue	1600000	usd
CY2022Q3	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Share Based Awards Other Than Options EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions	8000000	usd
CY2022	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1 EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1	P2Y10M24D
CY2022Q3	us-gaap	Letters Of Credit Outstanding Amount LettersOfCreditOutstandingAmount	53300000	usd
CY2022Q3	us-gaap	Special Assessment Bond SpecialAssessmentBond	632700000	usd
CY2022Q3	us-gaap	Deposits Assets DepositsAssets	10000000	usd
CY2022Q3	us-gaap	Purchase Obligation PurchaseObligation	490300000	usd
CY2022	us-gaap	Operating Lease Expense OperatingLeaseExpense	2500000	usd
CY2021	us-gaap	Operating Lease Expense OperatingLeaseExpense	1700000	usd
CY2020	us-gaap	Operating Lease Expense OperatingLeaseExpense	1100000	usd
CY2022Q3	us-gaap	Lessee Operating Lease Liability Payments Due Next Twelve Months LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths	2400000	usd
CY2022Q3	us-gaap	Lessee Operating Lease Liability Payments Due Year Two LesseeOperatingLeaseLiabilityPaymentsDueYearTwo	2400000	usd
CY2022Q3	us-gaap	Lessee Operating Lease Liability Payments Due Year Three LesseeOperatingLeaseLiabilityPaymentsDueYearThree	1900000	usd
CY2022Q3	us-gaap	Lessee Operating Lease Liability Payments Due Year Four LesseeOperatingLeaseLiabilityPaymentsDueYearFour	1400000	usd
CY2022Q3	us-gaap	Lessee Operating Lease Liability Payments Due Year Five LesseeOperatingLeaseLiabilityPaymentsDueYearFive	200000	usd
CY2022Q3	us-gaap	Lessee Operating Lease Liability Payments Due After Year Five LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive	0	usd
CY2022Q3	us-gaap	Number Of Units In Real Estate Property NumberOfUnitsInRealEstateProperty	61800	lot
CY2021Q3	us-gaap	Number Of Units In Real Estate Property NumberOfUnitsInRealEstateProperty	64400	lot
CY2021	for	Numberof Lots Sold NumberofLotsSold	15915	lot
CY2020	for	Numberof Lots Sold NumberofLotsSold	10373	lot
CY2022Q3	us-gaap	Due To Related Parties Current DueToRelatedPartiesCurrent	3200000	usd
CY2021Q3	us-gaap	Due To Related Parties Current DueToRelatedPartiesCurrent	6700000	usd
CY2022Q3	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	264800000	usd
CY2022Q3	us-gaap	Long Term Debt LongTermDebt	706000000.0	usd
CY2021Q3	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	153600000	usd
CY2021Q3	us-gaap	Long Term Debt LongTermDebt	704500000	usd

Files In Submission

Name	View Source	Status
0001406587-22-000128-index-headers.html	Edgar Link	pending
0001406587-22-000128-index.html	Edgar Link	pending
0001406587-22-000128.txt	Edgar Link	pending
0001406587-22-000128-xbrl.zip	Edgar Link	pending
a9302022ex211subsidiarylis.htm	Edgar Link	pending
a9302022ex231auditconsent.htm	Edgar Link	pending
a9302022exhibit311.htm	Edgar Link	pending
a9302022exhibit312.htm	Edgar Link	pending
a9302022exhibit321.htm	Edgar Link	pending
a9302022exhibit322.htm	Edgar Link	pending
a9302022exhibit43.htm	Edgar Link	pending
a9302022exhibit46.htm	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
for-20220930.htm	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
for-20220930.xsd	Edgar Link	pending
for-20220930_g1.jpg	Edgar Link	pending
for-20220930_g2.jpg	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
for-20220930_cal.xml	Edgar Link	unprocessable
for-20220930_lab.xml	Edgar Link	unprocessable
for-20220930_def.xml	Edgar Link	unprocessable
for-20220930_htm.xml	Edgar Link	completed
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
R9999.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
for-20220930_pre.xml	Edgar Link	unprocessable

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$FOR
Forestar Group Inc. Stock $for

2022 Q4 Form 10-K Financial Statement

#000140658722000128 Filed on November 17, 2022

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$FOR Forestar Group Inc. Stock $for

2022 Q4 Form 10-K Financial Statement

#000140658722000128 Filed on November 17, 2022

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$FOR
Forestar Group Inc. Stock $for